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siRNAs (18–22). Worm secondary siRNAs are 22-nt singlestranded RNAs with G as the 5′-terminal nt and antisense to the
target mRNA, and are often referred as 22G RNAs (23–25). Intriguingly, antiviral RNAi in C. elegans is also regulated by
Dicer-related RNA helicase 1 (DRH-1), which is highly homologous to mammalian RIG-I and is largely dispensable for exogenous RNAi (15). Whereas antiviral RNAi induced by a Flock house
virus (FHV)-based RNA replicon is dependent on drh-1, a reduced
replication of the FHV replicon is detected in mutant nematodes
defective in drh-2, which does not encode the N-terminal domains
(NTDs) found in drh-1 and drh-3 (15, 18).
The homologous DExD/H-box helicase domain of mammalian
RIG-I is ﬂanked by the N-terminal caspase recruitment domains
(CARDs) and a C-terminal regulatory domain (CTD). RIG-I
binding of the viral 5′-triphosphate dsRNA through the helicase
domain and CTD activates the downstream signaling events,
leading to the induction of IFN-dependent antiviral immunity (26–
28). The mammalian genomes also encode two additional RIG-I–
like RNA helicases (RLHs), melanoma differentiation-associated
gene 5 (MDA5), and laboratory of genetics and physiology 2
(LGP2). Both MDA5 and LGP2 contain CTD, but the N-terminal
CARDs are found only in MDA5. MDA5 senses viruses that are
not detected by RIG-I via a distinct strategy, whereas LGP2 seems
to function as a regulator of RIG-I and MDA5 activities through
a currently unknown mechanism (29, 30, 31–34).
In this study, we show that drh-1 and drh-3 of C. elegans are
essential for antiviral RNAi but exhibit distinct antiviral activities. Using a transgenic approach developed to assay for the
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I

nnate immunity refers to ancient host defense systems that act
immediately after pathogen attack and are under the control of
germline-encoded immune receptors. Pathogen sensing by several classes of immune receptors such as retinoic acid inducible
gene I (RIG-I)-like cytosolic sensors in mammals leads to the
transcriptional activation of effector genes in the nucleus (1). In
contrast, detection of viral double-stranded RNA (dsRNA) by
Dicer endonucleases is associated with the production of small
interfering RNAs (siRNAs), which subsequently direct sequencespeciﬁc antiviral immunity through RNA interference (RNAi)
(2–5). Antiviral RNAi is a major antiviral defense mechanism in
fungi, plants, insects, and nematodes, so that suppression of the
defense by a virus-encoded suppressor of RNAi is essential to
establish infection (6–8). Although the RNAi machinery is highly
conserved in mammals, conclusive evidence for a natural antiviral role of RNAi in mammals is not available (9).
The nematode Caenorhabditis elegans has recently emerged as
a small-animal model for innate immunity studies (10, 11). Genetic studies indicate that antiviral RNAi in C. elegans requires
the genes essential for RNAi induced by exogenous dsRNA (12–
17). These include Dicer-1 and dsRNA-binding protein RDE-4
(RNA interference-deﬁcient 4), involved in the biogenesis of
primary siRNAs predominantly 23 nt in length, and Argonaute
protein RDE-1 (RNA interference-deﬁcient 1) and RNA-dependent
RNA polymerase RRF-1, required for the production of secondary

www.pnas.org/cgi/doi/10.1073/pnas.1307453110

Signiﬁcance
Retinoic acid inducible gene I-like RNA helicases (RLHs) act as
virus sensors in mammalian antiviral immunity. RLHs also play
an essential role in antiviral RNAi in the nematode Caenorhabditis elegans through a currently unknown mechanism.
Here, we show that the retinoic acid inducible gene I domains
involved in virus sensing functionally replace the corresponding domain of Dicer-related RNA helicase 1 (DRH-1), one of
the worm RLHs, suggesting that DRH-1 contributes to antiviral
RNAi by acting as a virus sensor. Consistent with this observation, virus-derived primary siRNAs were signiﬁcantly reduced in drh-1 mutants. We further show that DRH-3, another
worm RLH that shares domain structure with DRH-1, is required
for the biogenesis of virus-derived secondary, but not primary,
siRNAs, suggesting that DRH-1 and DRH-3 contribute to antiviral RNAi through distinct mechanisms.
Author contributions: R.L. designed research; X.G., R.Z., J.W., and R.L. performed research;
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RNAi-mediated antiviral immunity in Caenorhabditis elegans requires Dicer-related helicase 1 (DRH-1), which encodes the helicase
and C-terminal domains homologous to the mammalian retinoic
acid inducible gene I (RIG-I)-like helicase (RLH) family of cytosolic
immune receptors. Here we show that the antiviral function of
DRH-1 requires the RIG-I homologous domains as well as its wormspeciﬁc N-terminal domain. We also demonstrate that the helicase
and C-terminal domains encoded by either worm DRH-2 or human
RIG-I can functionally replace the corresponding domains of DRH-1
to mediate antiviral RNAi in C. elegans. Notably, substitutions in
a three-residue motif of the C-terminal regulatory domain of RIG-I
that physically interacts with viral double-stranded RNA abolish
the antiviral activity of C-terminal regulatory domains of both RIG-I
and DRH-1 in C. elegans. Genetic analysis revealed an essential role
for both DRH-1 and DRH-3 in C. elegans antiviral RNAi targeting
a natural viral pathogen. However, Northern blot and small RNA
deep sequencing analyses indicate that DRH-1 acts to enhance
production of viral primary siRNAs, whereas DRH-3 regulates antiviral RNAi by participating in the biogenesis of secondary siRNAs
after Dicer-dependent production of primary siRNAs. We propose
that DRH-1 facilitates the acquisition of viral double-stranded RNA
by the worm dicing complex for the subsequent processing into
primary siRNAs. The strong parallel for the antiviral function of RLHs
in worms and mammals suggests that detection of viral doublestranded RNA may activate completely unrelated effector mechanisms or, alternatively, that the mammalian RLHs have a conserved
activity to stimulate production of viral siRNAs for antiviral immunity
by an RNAi effector mechanism.

antiviral function of drh-1 in whole animals, we examined the
antiviral activity of the predicted domains in DRH-1 and determined whether C. elegans antiviral RNAi could be mediated
by any of the conserved domains of human RIG-I protein. Our
results indicate that C. elegans antiviral RNAi requires an essential activity of DRH-1 to detect viral dsRNA in a manner
analogous to virus dsRNA sensing by RIG-I in mammals.
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Results
DRH-1 Is Required for Nematode Defense Against Infection by a Natural
Virus Pathogen. A antiviral role of DRH-1 was ﬁrst identiﬁed

through the characterization of antiviral RNAi induced by replication of FHV, which does not naturally infect C. elegans (15). A
recent report described identiﬁcation of a natural C. elegans virus,
Orsay virus, which is closely related to FHV and has been shown
to accumulate to signiﬁcantly enhanced levels in RNAi-defective
worm mutants such as rde-1 and rde-4 (16). We found that Orsay
virus infection was also markedly enhanced in worm mutants
carrying either of the two drh-1 loss-of-function alleles (Fig.
1A). This ﬁnding indicates that DRH-1 is also required for
natural antiviral defense in C. elegans.
To verify the antiviral RNAi function of DRH-1, we carried
out a transgene complementation assay in drh-1 mutant animals,
as illustrated in Fig. S1A. In this assay, plasmid Psur-5::DRH-1
that directed DRH-1 expression under the constitutively active
sur-5 promoter was injected into drh-1 mutant animals that carried
the chromosomally integrated transgene FR1gfp controlled by
a heat-inducible promoter (15). Heat treatment of drh-1;FR1gfp
worms is expected to induce replication of the FHV-based RNA
replicon and expression of the replicon-encoded green ﬂuorescence protein (GFP) from a subgenomic mRNA synthesized by
the FHV replicase. Because FR1gfp does not encode the RNAi
suppressor protein B2 (15), green ﬂuorescence would be undetectable if antiviral RNAi were restored in drh-1 mutant animals
by ectopic expression of DRH-1. We found that green ﬂuorescence indeed became undetectable in drh-1;FR1gfp worms after
gonad microinjection with Psur-5::DRH-1 (compare animals carrying Psur-5::DRH-1, marked by the red ﬂuorescence expressed
from the coinjected mCherry reporter plasmid, with animals
showing no red ﬂuorescence in heads; Fig. S1B). This ﬁnding
illustrated that ectopic expression of DRH-1 restored antiviral
RNAi in the drh-1 mutants.
To further conﬁrm this result, drh-1;FR1gfp worms carrying
a stably integrated Psur-5::DRH-1 transgene were generated and
used for the heat induction of FR1gfp or for Orsay virus infection. Northern blotting analysis showed that FR1gfp replication and Orsay virus infection were both suppressed in drh-1
mutants containing the Psur-5::DRH-1 transgene (Fig. 1 C and
D). These results together show that DRH-1 plays an essential
role in the worm antiviral RNAi induced by either FHV replication or Orsay virus infection.
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Both the NTD and CTD of DRH-1 Are Indispensable for Antiviral RNAi.

The DRH-1 function rescue assay established earlier made it
possible for us to map the domain requirement in the antiviral
function of DRH-1. In addition to the DEAD-box RNA helicase
domain, DRH-1 contains a worm-speciﬁc NTD and a conserved
C-terminal regulatory domain originally identiﬁed in RIG-I (35).
We generated four domain deletion mutants of DRH-1 (Fig. 1B),
named DRH-1NTD, DRH-1DHC, DRH-1NDH, and DRH1NDHp, and examined their antiviral activity using the DRH-1
function rescue assay. We found that ectopic expression of none
of these four DRH-1 mutants restored antiviral RNAi in drh-1;
FR1gfp worms (Fig. S1B), indicating that both of the terminal
domains of DRH-1 are essential for its antiviral function. As a
further conﬁrmation, we generated chromosomal integrants carrying nuclear transgenes corresponding to each of these DRH-1
deletion mutants and assayed for both FR1gfp replication and
16086 | www.pnas.org/cgi/doi/10.1073/pnas.1307453110
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Fig. 1. Both the NTD and CTD of DRH-1 are indispensable for antiviral RNAi.
(A) Accumulation of Orsay virus RNA1 detected by Northern blot in wild-type
worms and genetic mutants, as indicated. Methylene blue-stained ribosomal
RNA (rRNA) serves as equal loading control. JU1580, an isolate of C. elegans
that is defective in antiviral RNAi; N2, the Bristol isolate of wild type C.
elegans. (B) Schematic structure of DRH-1 and its derivatives used in the
DRH-1 function rescue assay. CTD, C-terminal regulatory domain originally
identiﬁed in RIG-I; helicase C, the RNA helicase superfamily C-terminal domain; NTD, N-terminal domain. DExD/H, the DEAD-box superfamily domain.
(C) Northern blot detection of FR1gfp transcripts in drh-1 mutants carrying
the integrated transgenes corresponding to wild-type DRH-1 or its derivatives, as indicated, 48 h after heat induction. Methylene blue-stained ribosomal RNA serves as equal loading control. (D) Orsay virus RNA1 detected
by Northern blot in drh-1 mutants carrying the integrated transgenes corresponding to wild-type DRH-1 or its derivatives, as indicated, 72 h after
virus inoculation.

Orsay virus infection in the selected animal lines. Northern blot
analysis (Fig. 1 C and D) showed that neither FR1gfp replication
nor Orsay virus infection was suppressed in integrants carrying any
of the DRH-1 domain deletion mutants in contrast to the control
integrants carrying the wild-type DRH-1 transgene. Western blotting suggested stable expression of both DRH-1NTD and DRH1NDH examined in transgenic worms by C-terminal tagging with
an HA epitope (Fig. S1 C and D). These results together indicate
that in addition to the central helicase domains, both NTD and
CTD of DRH-1 are indispensable for antiviral RNAi.
The Predicted Domains of DRH-2 Were Functional in a Fusion Protein
with the NTD of DRH-1. The predicted DRH-2 protein is highly

homologous to DRH-1 (Fig. S2) but lacks the worm-speciﬁc
NTD plus one of the three motifs in the DEAD-box helicase
domain. We determined whether use of the predicted protein
domains of DRH-2 to replace the corresponding domains of
DRH-1 produced a chimeric protein capable of mediating antiviral
Guo et al.

The Helicase and CTD Domains of RIG-I Were Functional in a Fusion
Protein with the NTD of DRH-1. An essential role for both the NTD

and CTD of DRH-1 in the antiviral defense is analogous to the
domain requirement of mammalian RIG-I (36). DRH-1 shares
signiﬁcant sequence homology in the RNA helicase and CTD
domains with RIG-I (Fig. S4), although by comparison, DRH-1
and RIG-I are more distantly related than DRH-1 and DRH-2.
We found that transgenic expression of human RIG-I or a truncation mutant removing the N-terminal CARD domains (RIG-
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IDHC) in drh-1;FR1gfp worms did not suppress replication of
FR1gfp (Fig. 3A and Fig. S5A). Because the worm-speciﬁc NTD
of DRH-1 was indispensable in antiviral RNAi, we next determined the antiviral activity of a DRH-1/RIG-I chimeric protein termed D1RIG-I, in which the N-terminal CARD domains
of human RIG-I were replaced with the NTD of DRH-1 (Fig.
3A). As shown in Fig. S5A, ectopic expression of D1RIG-I, but
not D1RIG-IND, effectively restored antiviral RNAi in drh-1;
FR1gfp worms, indicating that the helicase domain and CTD of
RIG-I confer biological function similar to what the corresponding
DRH-1 domains do. Similarly, antiviral RNAi was also restored
by another DRH-1/RIG-I chimeric protein, D1RIG-ID1C, in
which only the central helicase domain of DRH-1 was replaced
by the corresponding domain of RIG-I (Fig. 3A and Fig. S5A).
This ﬁnding showed that antiviral RNAi was mediated by the
helicase domain of RIG-I in the context of the NTD and CTD
of DRH-1.
As described earlier, we further generated stable animal lines
carrying each of these DRH-1/RIG-I chimeric constructs and
assayed for both FR1gfp replication and Orsay virus infection in
the selected animal lines. Consistent with earlier observations,
replication of both FR1gfp and Orsay virus was signiﬁcantly
inhibited in stable transgenic animals constitutively expressing
D1RIG-I, and heat-inducible expression of D1RIG-ID1C restored antiviral RNAi to an extent comparable with that restored
by D1RIG-I (Fig. 3 B–D). As observed earlier for D1D2, the
heat-inducible promoter directed a more efﬁcient rescue on
DRH-1 function in antiviral FR1gfp silencing than the constitutive promoter (Fig. 3B). These results together indicate that
either of the RNA helicase and CTD domains of RIG-I is
competent to functionally replace the homologous domain of
DRH-1 in antiviral RNAi in C. elegans.
Previous structural studies showed that a KWK motif in the
CTD of RIG-I mediates physical interaction between RIG-I
and dsRNA, although it is unknown whether the interaction is
functionally important (26, 27, 37). Because the KWK motif is
conserved in DRH-1 CTD (Fig. S5B, Upper), we next determined
whether this motif is critical for antiviral RNAi in C. elegans. To
this end, we introduced alanine substitutions into the KWK
motif in the CTD domains of both DRH-1 and D1RIG-I and
subjected the resulting mutant constructs, DRH-1AAA and
D1RIG-IAAA, to DRH-1 function rescue assay. As shown in
Fig. S5B (Lower) and Fig. S5C, expression of either mutant was
unable to restore DRH-1 function in antiviral RNAi against
FR1gfp. These ﬁndings strongly suggest that antiviral RNAi
mediated by DRH-1 involves an essential activity of DRH-1 to
detect viral dsRNA in a manner analogous to virus dsRNA
sensing by RIG-I in mammals.
DRH-3 Regulates Antiviral RNAi by a Mechanism Distinct from DRH-1.
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rRNA
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Fig. 2. The putative domains encoded by DRH-2 mediate antiviral RNAi
when fused with the NTD of DRH-1. (A) Schematic structure of DRH-1, DRH-2,
and their domain variants. See Fig. 1B and main text for more details. (B)
Accumulation of FR1gfp transcripts detected by Northern blot in drh-1
mutants carrying the integrated transgenes corresponding to wild-type
DRH-1, putative DRH-2, or their domain variants, as indicated. HI denotes
DRH-1 function rescue using a heat-inducible promoter for candidate gene
expression. (C) Accumulation of Orsay virus RNA1 detected by Northern blot
in drh-1 mutants carrying the integrated transgenes corresponding to wildtype DRH-1, putative DRH-2, or their domain variants, as indicated. OK3495,
a DRH-1 variant encoded by the ok3495 allele.

Guo et al.

DRH-3 shares a similar domain structure with DRH-1 but
contains more divergent sequences compared with DRH-1 and
DRH-2 (Fig. S6). Recent studies have shown that DRH-3 is
required for germline development and RNAi by participating in
the biogenesis of 22G RNAs (25, 38, 39), suggesting a possible
role for DRH-3 in antiviral RNAi. We investigated FHV replication and Orsay virus infection in worms containing the ne4253
allele of drh-3. A single amino acid change occurred in the
helicase C domain of DRH-3 encoded by the ne4253 allele, and
as a result, worms containing this allele are defective in dsRNAinduced RNAi in the somatic tissues (25). We found that drh-3
mutant worms were highly susceptible to Orsay virus infection
(Fig. 4A, Upper). Northern blot analysis detected a similarly highlevel replication of Orsay virus in drh-3, drh-1, and JU1580 mutant worms. Moreover, we found that FR1gfp also replicated to
higher levels in drh-3 mutant worms compared with wild-type N2
worms (Fig. 4A, Lower). These ﬁndings indicate that DRH-3
indeed plays a role in worm antiviral RNAi.
PNAS | October 1, 2013 | vol. 110 | no. 40 | 16087

IMMUNOLOGY

RNAi in drh-1 mutant background. We found that ectopic expression of such a chimeric protein, D1D2 (Fig. 2A), was associated with loss of GFP expression in drh-1;FR1gfp worms
(Fig. S3A), indicating rescue of DRH-1 function in antiviral
RNAi by D1D2 driven by the constitutive sur-5 promoter. We
next generated stable animal lines expressing D1D2 driven by
either sur-5 or the heat-inducible promoter in drh-1;FR1gfp
background. Northern blot analysis showed that expression of
D1D2 driven by the sur-5 promoter suppressed the replication of
both FR1gfp and Orsay virus in the drh-1 mutant background
(Fig. 2 B and C). Notably, expression of D1D2 using the heatinducible promoter conferred stronger antiviral RNAi targeting
FR1gfp replicon (Fig. 2B). However, transgenic expression of
DRH-2, the region of DRH-1 equivalent to DRH-2 (DRH1DHC*), or the N-terminal region of DRH-1 absent in DRH-2
(DRH-1NTD*), was insufﬁcient to rescue DRH-1 function (Fig.
2 A–C and Fig. S3A). Epitope-tagging and Western blotting assay suggested stable expression of DRH-1NTD*, DRH-1DHC,*
and DRH-1 in transgenic worms (Fig. S3B). Thus, these ﬁndings
indicate that when expressed as a fusion protein with the NTD of
DRH-1, the predicted helicase and CTD domains of DRH-2
mediate antiviral RNAi as effectively as the corresponding
domains of DRH-1.
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Fig. 3. The RNA helicase and CTD domains of RIG-I functionally replace the
corresponding domains of DRH-1 in antiviral RNAi. (A) Schematic structure
of RIG-I and its domain variants. (B) Accumulation of FR1gfp transcripts
detected by Northern blot in drh-1 mutants carrying the integrated transgenes corresponding to wild-type DRH-1 or RIG-I domain variants, as indicated. HI denotes DRH-1 function rescue using a heat-inducible promoter
for candidate gene expression. (C) Accumulation of Orsay virus RNA1 detected
by Northern blot in drh-1 mutants carrying the integrated transgenes corresponding to wild-type DRH-1 and D1RIG-I. (D) Accumulation of FR1gfp transcripts detected by Northern blot in drh-1 mutants carrying the integrated
transgenes corresponding to wild-type DRH-1, D1RIG-I, and D1RIG-ID1C.

To deﬁne a role for DRH-3 in antiviral RNAi, we compared
the accumulation of FR1gfp-derived viral siRNAs in drh-1 and
drh-3 mutants, using control mutants known to be defective in
the biogenesis of primary siRNAs (rde-4) or secondary siRNAs
(rde-1 and rrf-1) (21, 40, 41). Consistent with previous deep sequencing results (40, 42), several species of viral siRNAs were
detected in the rde-1 mutants, with a major band detected at the
position corresponding to 23 nt (Fig. 4B). Viral siRNAs also
accumulated to readily detectable levels in both drh-3 and rrf-1
mutants, with a dominant 23-nt band similar to that in rde-1
mutants (Fig. 4B and Fig. S7), indicating robust production of
viral primary siRNAs in drh-3, rde-1, and rrf-1 mutants. In comparison, viral siRNAs including the 23-nt species reproducibly
accumulated to much lower levels in both drh-1 and rde-4 mutants
than in rde-1 and drh-3 mutants, even though the FR1gfp replicated to comparable levels in rde-1, drh-1, and drh-3 mutants (Fig.
4 A and B and Fig. S7).
Our ﬁndings suggested a major defect of drh-1 mutant animals
in the biogenesis of primary viral siRNAs as in rde-4 mutant
animals. In contrast, loss of antiviral RNAi in drh-3 mutant
animals was not associated with defective biogenesis of viral
primary siRNAs, suggesting that DRH-3 may regulate the biogenesis of viral secondary siRNAs, as demonstrated for its role in
exogenous RNAi (25). To test this idea, we compared the viral
siRNA proﬁles in drh-3 and rrf-1 mutant animals through deep
sequencing, using a cloning protocol capturing both primary and
secondary siRNAs. As found in studies on exogenous RNAi (21,
40, 41), rrf-1 mutant animals produced a typical population of
primary siRNAs, as the sequenced viral siRNAs were predominantly 23 nt in length, contained similar reads number for
positive and negative strands, and were not enriched for 22-nt
siRNAs with 5′-terminal guanine nt (Fig. 4C, Left). We found
that the proﬁle of viral siRNAs sequenced from drh-3 mutant
animals (Fig. 4C, Right) was highly similar to that from rrf-1
mutant animals and lacked a population of 22G RNAs. These
16088 | www.pnas.org/cgi/doi/10.1073/pnas.1307453110

DRH-1 Is Dispensable for RNAi Targeting Cellular Transcripts. In
contrast to antiviral RNAi, DRH-1 is largely dispensable in
RNAi induced artiﬁcially to target cellular transcripts of endogenous genes such as skn-1, dpy-13, and unc-22 (15) or
transgene (Fig. S8). Our recent study has detected RNAi of
cellular mRNAs targeted by virus-derived siRNAs in C. elegans
(43). Because low levels of FR1gfp-derived viral siRNAs remained
detectable in drh-1 mutants (Fig. 4B), we next determined whether
these viral siRNAs were active in RNAi targeting cellular transcripts in the absence of DRH-1. To test this hypothesis, we used
a transgenic worm strain carrying a Psur-5::GFP transgene and
a previously described replicon transgene, FR1fp, which does not
express GFP because of deletion of the 5′-half of the GFP coding
sequence but triggers potent silencing of the homologous cellular
GFP transcripts (43) (Fig. S9A). As expected, FR1fp replication
triggered potent gfp silencing, manifested as a reduction in the
intensity of green ﬂuorescence in the wild-type N2 worms but not
in RNAi-defective mutants corresponding to rde-1 or rde-4 (Fig.
S9B). Consistently, FR1fp-derived siRNAs accumulated at lower
levels in drh-1 mutants than in rde-1 mutants (Fig. 5A). We also
detected gfp silencing in drh-1 mutants, albeit to a lesser extent
(Fig. S9B). Northern blot analysis showed that the gfp transcripts
were markedly reduced in wild-type N2 worms and drh-1 mutants,
but not in drh-1 double mutants with rde-1 or rde-4 (Fig. 5B). In
contrast, both RNAs 1 and 3 from replicon FR1fp accumulated to
high levels in all of the examined drh-1, rde-1, and rde-4 single and
double mutants (Fig. 5B). These ﬁndings showed that drh-1 was
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of viral secondary siRNAs.
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Fig. 4. DRH-3 regulates antiviral RNAi by a mechanism distinct from DRH-1.
(A, Upper) Accumulation of Orsay virus RNA1 detected by Northern blot in
JU1580, wild-type N2 worms, and genetic mutants defective in drh-3 or drh-1,
as indicated. (Lower) Accumulation of FR1gfp transcripts detected by
Northern blot in wild-type N2 worms and genetic mutants defective in drh-3,
rde-1, or drh-1, as indicated. (B) Accumulation of FR1gfp-derived siRNAs
detected by Northern blot in different genetic backgrounds, as indicated.
(Lower) Shorter-exposure image of the same blot. (C) Primary and secondary
FR1gfp-derived siRNA populations in rrf-1 and drh-3 mutants. The reads are
grouped based on polarity and according to length and the identity of the
ﬁrst nucleotide.
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Discussion
It is intriguing that, as an essential component of the nematode
antiviral RNAi, DRH-1 encodes the helicase domain and
CTD homologous to mammalian RLHs, as RLHs initiate the
IFN-dependent antiviral immunity that is absent in C. elegans
(15). In this study, we developed an assay to dissect the domain
requirement of DRH-1 in antiviral RNAi against both the FHV
replicon and Orsay virus by transgenic expression of the wild-type
and mutant forms of DRH-1 in animals carrying a loss-of-function
allele of drh-1. Our results show that the antiviral activity of DRH1 requires its helicase domain and CTD, as well as the wormspeciﬁc NTD. We also demonstrate that the homologous helicase
and CTD domains encoded by either the worm DRH-2 or human
RIG-I can functionally replace the corresponding domains of
DRH-1 to mediate antiviral RNAi in C. elegans. Strikingly, three
amino acid substitutions in the KWK motif predicted to prevent
the physical interaction of RIG-I with viral dsRNA abolished the
antiviral activity of the CTDs of both RIG-I and DRH-1 in C.
elegans. These ﬁndings strongly suggest that antiviral RNAi in C.
elegans requires an activity of DRH-1 to detect viral dsRNA known
to be essential for the virus sensing by RIG-I.
Available data illustrate an identical genetic requirement for
antiviral RNAi triggered by either the replication of FHV or the
infection of Orsay virus (12–16). This is probably because induction of nematode antiviral RNAi requires the recognition
and processing (into siRNAs) of dsRNA produced during RNA
virus replication, and Orsay virus is closely related to FHV (16).
Consistently, we found in this study that DRH-1 identiﬁed in
a feeding RNAi screen on the basis of the FHV replicon-induced
antiviral RNAi is also necessary for the nematode defense against
Orsay virus infection. Moreover, we show that antiviral RNAi
induced by both the FHV replicon and Orsay virus requires
DRH-3. We note that DRH-3 is known to participate in exogenous and endogenous RNAi of C. elegans (25, 38) in contrast to
DRH-1, which is largely dispensable for RNAi targeting cellular
transcripts, whether or not the silencing siRNAs are processed
from a replicating viral RNA or an exogenous long dsRNA.
Using an improved protocol for Northern detection of small

B

A

RNAs (43), we found that the 23-nt primary siRNAs targeting
the FHV replicon reproducibly accumulated to higher levels in
drh-3 mutants than in drh-1 mutants, although both mutants
supported similar replication levels of the replicon. Deep sequencing further indicated that the abundant viral siRNAs produced in drh-3 mutants did not include a population of secondary
siRNAs. These observations together indicate that DRH-3 regulates RNAi targeting both cellular transcripts and viruses by
participating in the biogenesis of secondary siRNAs after Dicerdependent production of primary siRNA biogenesis, as proposed
previously for its role in endogenous RNAi (25). In contrast,
DRH-1 may act to speciﬁcally enhance production of viral primary siRNAs by facilitating the recruitment of the heterodimer
DCR-1/RDE-4 to the viral dsRNA bound by DRH-1 for subsequent processing into primary siRNAs by DCR-1. Our model
is consistent with a previous study that detected physical interaction of RDE-4 with DRH-1, but not with DRH-3 (18), and
would also explain why the function of DRH-1 is essential only
for RNAi against virus infection.
Viral RNA replication occurs in discrete subcellular compartments such as the spherules on the outer membrane of mitochondria shown for FHV (44). Virus dsRNA replicative intermediates
are also found in complexes with viral replicase and host cofactor
proteins. These physical barriers may prevent the DCR-1/RDE-4
complex from gaining access to viral dsRNA. DRH-1-mediated
detection of the unique viral dsRNA for the production of primary siRNAs may be particularly important to ensure effective
RNAi against the replicating viral RNAs in C. elegans, which
encodes only one Dicer, unlike multi-Dicer plant and insect
hosts that process distinct siRNA and miRNA precursors with
dedicated Dicer proteins (4). However, production of primary
siRNAs in the absence of DRH-1 may still be sufﬁcient for RNAi
to target the nonreplicating cellular transcripts.
Rapid progress has been made in understanding the IFNregulated effector mechanism of the mammalian antiviral immunity initiated by RIG-I, MDA5, and LGP2 in the cytosol (45).
Our study provides an interesting parallel for a three-member
family of RLHs to regulate antiviral defense in C. elegans, using
RNAi as the effector mechanism. Analogous to the role of the
N-terminal CARDs of RIG-I in the downstream immune signaling (45), the interaction of DRH-1 with RDE-4 may involve
the worm-speciﬁc NTD of DRH-1, which is critical for the use of
RNAi as the effector mechanism. Therefore, detection of viral
dsRNA by related RLHs in nematodes and mammals activates
unrelated effector mechanisms, illustrating functional diversiﬁcation
of RLHs during evolution via acquisition of speciﬁc N-terminal
signaling domains. An alternative model is that the mammalian
RLHs have a conserved activity to recruit DCR-1 for the production of viral siRNAs to activate antiviral immunity by an
RNAi effector mechanism.
Materials and Methods
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Fig. 5. DRH-1 is not required for the silencing of cellular transcripts mediated by viral siRNAs. (A) Accumulation of FR1fp-derived siRNAs detected by
Northern blot in wild-type N2 worms and genetic mutants defective in rde-1,
rde-4, and drh-1, as indicated. (B) Northern blot detection of GFP silencing
triggered by FR1fp replication in different genetic backgrounds, as indicated, 48 h after heat induction. The GFP transcripts were detected using
oligo probes that would not hybridize to the FP region of FR1fp.
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Genetics. The Bristol isolate of C. elegans, N2, was used as the reference strain
in this study. Other N2-derived mutants used in this study include rde-1
(ne300), rde-4(ne337), drh-1 (tm1329 and ok3495), and drh-3 (ne4253). The
genotypes of rde-1 and rde-4 worms were conﬁrmed using skn-1 feeding
RNAi combined with genomic DNA sequencing. The genotype for drh-1 allele tm1329 was identiﬁed using PCR, as described previously (15). The
genotypes of drh-3 mutants were conﬁrmed through genomic DNA sequencing. All worm strains were maintained on NGM (nematode growth
medium) plates seeded with OP50 bacteria unless otherwise indicated. All
transgenes were delivered into various genetic backgrounds through standard genetic crosses.
Plasmid Constructs and Transgenic Worms. All plasmids constructed for constitutive expression of the target genes were based on the LR50 vector (46); all
of the constructs featuring inducible expression used the pPD49.83 vector
(kind gift from A. Fire, Stanford University, Stanford, California).
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essential for silencing a replicating viral replicon, but not a homologous cellular mRNA targeted by the same pool of siRNAs in the
same animals. In an independent set of experiments, we compared
the susceptibility of the replicating FR1fp and cellular GFP mRNA
to feeding RNAi and found that cellular transcripts remained highly
susceptible, unlike the viral replicon (Fig. S10). Therefore, we
propose that unlike drh-3, which is required for both exogenous
RNAi and antiviral RNAi, participation of an additional drh-1
pathway is necessary to inhibit virus infection.
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Infectious Filtrate Preparation and Orsay Virus Inoculation. Orsay virus was
maintained using the JU1580 isolate at room temperature following a protocol described previously (16). To prepare Orsay virus inoculum, infected
JU1580 worms were washed off from slightly starved 10-cm plates using M9
buffer, 5 mL per plate. The virus-containing liquid was then ﬁltered through
a 0.22-μm ﬁlter unit (Millipore) and used to resuspend pelleted OP50
Escherichia coli for NGM plate seeding.

Small RNA Sequencing. RNA extracts containing enriched small RNAs were
used for the construction of small RNA libraries. To capture virus-derived secondary siRNAs, all input RNA samples were treated with tobacco acid pyrophosphatase (Epicentre) before being used for small RNA library construction.
All small RNA libraries were generated using TruSeq RNA Sample Preparation
Kit (Illumina), following the manufacture’s instructions, and sequenced using
the Illumina HiSeq2000. After the adaptor was removed, the small RNA
sequences were analyzed with in-house pipelines, as described previously (47).

Protein and RNA Gel Blot Analysis. Total proteins were extracted from worms
of mixed stages and were resolved on 8% (wt/vol) SDS/PAGE gel. After being
transferred to Hybond-P PVDF membrane (GE Healthcare Life Science), the
target proteins were detected with anti-HA as primary antibody and goat
anti-rabbit secondary antibody (Cell Signaling Technology). As equal loading
control, the same set of samples of equal amount was subjected to protein
gel blot analysis using anti–β-actin antibody.
Total RNA extraction, small RNA enrichment, detection of viral and cellular
transcripts, and small RNAs were carried out following protocols described
previously (43, 46). DNA oligos with sequence ATTGCCGTACTGAACGATCTCA
were labeled and used for the detection of miR-58.

Imaging Microscopy. GFP and mCherry ﬂuorescence images were recorded
using a Nikon p7000 digital camera mounted on a Nikon SMZ1500
microscope.
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